Sunshine Heart Inc


Canaccord Pounds the Table on Sunshine Heart Inc

Canaccord Genuity analyst Jason Mills was out pounding the table on Sunshine Heart Inc (NASDAQ:SSH) Thursday, reiterating a Buy rating and a $7.50 price target, which represents a potential …

Canaccord Praises Sunshine Heart (SSH) Following FDA Approval For Interim Analysis

Canaccord Genuity analyst Jason Mills came out today with a favorable report on Sunshine Heart Inc (NASDAQ:SSH), following the news that the company received unconditional …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts